MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CAH — Cardinal Health, Inc.
NYSECardinal Health, Inc.
$228.30
-1.79(-0.78%)
- O
- 229.54
- H
- 231.10
- L
- 224.45
- V
- 1.81M
⏱️ End-of-day dataAs of Oct 2, 2026
Cardinal Health, Inc. Statistics
Total Valuation
| Market Cap | $50.99B |
| Enterprise Value | $51.00B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | 2026-10-01 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 232.58M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | 135.09 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 30,407.87 |
| P/OCF Ratio | 30,608.64 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 134,206.07 |
| EV / Sales | n/a |
| EV / EBITDA | 47,484.46 |
| EV / EBIT | 103,444.84 |
| EV / FCF | 30,410.44 |
Financial Position
| Current Ratio | 0.91 |
| Quick Ratio | n/a |
| Debt / Equity | -3.09 |
| Debt / EBITDA | 7.68 |
| Debt / FCF | 4.92 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | -14.22% |
| Return on Assets (ROA) | 0.67% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $6 |
| Employee Count | 63,900 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | $12.00K |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | +44.07% |
| 50-Day Moving Average | $232.67 |
| 200-Day Moving Average | $218.03 |
| Relative Strength Index (RSI) | 39.89 |
| Average Volume (20 Days) | 1,882,311 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $2.50M |
| Operating Income | $842.00K |
| Pretax Income | $392.00K |
| Net Income | $380.00K |
| EBITDA | $1.07M |
| EBIT | $493.00K |
| Earnings Per Share | $1.69 |
Balance Sheet
| Cash & Cash Equivalents | $3.94M |
| Total Debt | $8.24M |
| Net Cash | -$4.31M |
| Net Cash Per Share | $-0.02 |
| Equity (Book Value) | -$2.67M |
| Book Value Per Share | $-0.01 |
| Working Capital | -$3.92M |
Cash Flow
| Operating Cash Flow | $1.67M |
| Capital Expenditures | -$146.00K |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | $1.68M |
| FCF Per Share | $0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | $2.06 |
| Dividend Yield | 0.90% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.74% |
| FCF Yield | 0.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | $25.35 |
| Lynch Upside | -88.90% |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |